心臓代謝指数への累積的な暴露と心不全のリスクとの関連:前向きなコホート研究
Peng Fu1,2, Huancong Zheng3, Weiqiang Wu1
1Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, No. 69, Dongxia North Road, Jinping District, Shantou, Guangdong Province 515000, China.
ESC heart failure
|February 19, 2026
まとめ
高累積心代謝指数 (CMI) は,時間の経過とともに心不全 (HF) のリスクを大幅に増加させます. 最適なCMIレベルを維持することは,一般人口のHF予防に不可欠です.
科学分野:
- 心臓病学 心臓病学
- 予防医学は,予防的な医療です.
- エピデミオロジー エピデミオロジー
背景:
- 高い心代謝指数 (CMI) は,心不全 (HF) の既知の危険因子です.
- インシデントHFに対する累積CMI被曝の長期的な影響については,さらなる調査が必要である.
研究 の 目的:
- 累積CMI曝露とインシデントHFの発生リスクとの関連を検証する.
- 大規模な潜在的なコホートにおける心不全発生率に対する累積CMIの長期的な影響を評価する.
主な方法:
- Kailuan Studyの44,773人の参加者のデータを利用し,2006年,2008年,2010年のベースラインの健康診断を行った.
- 累積CMIを計算し,四分位に分類し,2022年12月までの医療記録と死亡記録を通じて特定されたインシデントHFを四分位に分類しました.
- HFリスクの危険比率と95%信頼区間を推定するために,コックス比例危険モデルを使用した.
主要な成果:
- フォローアップ期間 (平均12.0年) で,HFイベントが1018件発生しました.
- 最も低い四分位数と比較して,最も高い四分位数 (Q2-Q4) の累積CMIは,HFに対する調整された危険比率 (P for trend < 0.001) を大幅に増加させた.
- 累積CMIと糖尿病 (P=0.043) の間には有意な相互作用が認められたが,年齢,性別,高血圧は認められなかった.
結論:
- 高累積心代謝指数は,心不全のリスクの増加と独立して関連しています.
- 長期的なモニタリングと最適なCMIレベルを維持することは,HFの早期発見と予防の鍵となる戦略である可能性があります.
関連する概念動画
Heart Failure IV: Classification and Diagnostic Evaluation
594
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
594
Heart Failure II: Pathophysiology
1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Heart Failure I: Introduction
1.3K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Coronary Artery Disease I: Introduction
1.6K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Mitral Regurgitation I: Introduction
1.0K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.0K
Pathophysiology of Heart Failure
4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K

